Cell-surface Expression of Lymphocyte Activation Markers in Myasthenia Gravis

References

• Patrick J., Lindslrom J. Autoimmune response to acetylcholine receptors. Science 1973; 180: 871–872
   PubMed Web of Science ®Google Scholar
• Ragheb S., Lisak R. P. The immunopathogenesis of acquired (auto-immune) myasthenia gravis. Handbook of Myasthenia Gravis and Myasthenic Syndromes, R. P Lisak. Dekker. 1994; 239–276
   Google Scholar
• Engel A. G., Lambert E. H., Howard F. M. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiological correlations. Mayo Clin. Proc 1977; 52: 267–280
   PubMed Web of Science ®Google Scholar
• Drachman D. B., Adams R. N., Josifek L. F., Self S. G. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N. Engl. J. Med 1982; 307: 769–775
   PubMed Web of Science ®Google Scholar
• Ashikawa T., Appel S. H. Immunopathologic events at the endplate in myasthenia gravis. Springer Sem. Imimino-pathol 1985; 8: 177–196
   PubMed Web of Science ®Google Scholar
• Appel S. H., Almon R. R., Levy N. R. Acetylcholine receptor antibodies in myasthenia gravis. N. Engl. J. Med 1975; 293: 760–761
   PubMed Web of Science ®Google Scholar
• Lindstrom J. M., Seybold M. E., Lennon V. A., Whittingham S., Duane D. D. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates and diagnostic value. Neurology 1976; 26: 1054–1059
   PubMed Web of Science ®Google Scholar
• Limburg P. C., The T. H., Hummel-Tappel W. H., Oosterhuis J. G.H. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part I. Relation to clinical parameters in 250 patients. J. Neurol. Sci 1983; 58: 457–470
   Google Scholar
• Shinomiya N., Yata J. B and T cell involvement in anti-acetylcholine receptor antibody formation in myasthenia gravis. Clin. Exp. Immunol 1981; 46: 277–285
   PubMed Web of Science ®Google Scholar
• Willcox H. N.A., Newsom-Davis J., Calder L. R. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis. Clin. Exp. Immunol 1984; 58: 97–106
   PubMed Web of Science ®Google Scholar
• Limburg P. C., Hummel-Tappel E., Oosterhuis H. J., T. H. The. In vitro T-cell dependent B-cell activity in myasthenia gravis. Clin. Exp. Immunol 1985; 61: 31–38
   PubMedGoogle Scholar
• Castleman B. The pathology of the thymus gland in myasthenia gravis. Ann. N. Y. Acad. Sci 1966; 135: 496–503
   PubMed Web of Science ®Google Scholar
• Goldstein G. Myasthenia gravis and the thymus. Ann. Rev. Med 1971; 22: 119–124
   PubMedGoogle Scholar
• Abdou N. I., Lisak R. P., Zweiman B., Abrahamson I., Penn A. S. The thymus in myasthenia gravis. Evidence for altered cell populations. N. Engl. J. Med 1974; 291: 1271–1275
   PubMedGoogle Scholar
• Aharonov A., Tarrab-Hazdai R., Abramsky O., Fuchs S. Immunological relationships between acetylcholine receptor and thymus: a possible significance in myasthenia gravis. Proc. Nail. Acad. Sci. USA 1975; 72: 1456–1459
   PubMedGoogle Scholar
• Engel W. K., Trotter M. L., McFarlin D. E., McIntosh C. L. Thymic epithelial cell contains acetylcholine receptor. Lancet 1977; 1: 1310–1311
   PubMedGoogle Scholar
• Kao I., Drachman D. B. Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. Science 1977; 195: 74–75
   PubMed Web of Science ®Google Scholar
• Vincent A., Scadding G. K., Thomas H. C., Newsom-Davis J. In vitro synthesis of anti-acetylcholine receptor antibody by thymic lymphocytes in myasthenia gravis. Lancet 1978; 1: 778–779
   Google Scholar
• Kornstein M. J., Brooks J. J., Anderson A. O., Levinson A. I., Lisak R. P., Zweiman B. The immunohistology of the thymus in myasthenia gravis. Am. J. Pathol 1984; 117: 184–194
   PubMedGoogle Scholar
• Levinson A. I., Zweiman B., Lisak R. P., Dziarski A., Moskovitz A. R. Thymic B-cell activation in myasthenia gravis. Neurology 1984; 34: 462–468
   PubMedGoogle Scholar
• F'ujii Y., Monden Y., Nakahara K., Hashimoto J., Kawashima Y. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma. Neurology 1984; 34: 1182–1186
   PubMedGoogle Scholar
• Lisak R. P., Levinson A. I., Zweiman B., Kornstein M. J. Antibodies to acetylcholine receptor and tetanus toxoid: in vitro synthesis by thymic lymphocytes. J. Immunol 1986; 137: 1221–1225
   PubMedGoogle Scholar
• Schluep M., Willcox N., Ritter M. A., Newsom-Davis J., Larche M., Brown A. N. Myasthenia gravis thymus: clinical, histological and culture correlations. J. Autoimmunity 1988; 1: 445–467
   PubMed Web of Science ®Google Scholar
• Melms A., Schalke B. C.G., Kirchner T., Muller-Hermelink H. K., Albert E., Wekerle H. The thymus in myasthenia gravis: isolation of T lymphocyte lines specific for the nicotinic acetylcholine receptor from the thymuses of myasthenic patients. J. Clin. Invest 1988; 81: 902–907
   PubMed Web of Science ®Google Scholar
• Sommer N., Willcox N., Harcourt G. C., Newsom-Davis J. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann. Neurol 1990; 28: 312–319
   PubMed Web of Science ®Google Scholar
• Nelson S., Conti-Tronconi B. M. Adult thymus expresses an embryonic nicotinic acetylcholine receptorlike protein. J. Neuroimmunal 1990; 29: 81–92
   PubMed Web of Science ®Google Scholar
• Wheatley L. M., Urso D., Tumas K., Maltzman J., Loh E., Levinson A. I. Molecular evidence for the expression of nicotinic acetylcholine receptor o-chain in mouse thymus. J. Immunol 1992; 148: 3105–3109
   PubMedGoogle Scholar
• Cohen-Kaminsky S., Gaud C., Morel E., Berrih-Aknin S. High recombinant 1L-2 sensitivity of peripheral blood lymphocytes from patients with myasthenia gravis: correlations with clinical parameters. J. Autoimmunity 1989; 2: 241–258
   PubMedGoogle Scholar
• Cohen-Kaminsky S., Levasseur P., Binet J. P., Berrih-Aknin S. Evidence of enhanced recombinant interleukin-2 sensitivity in thymic lymphocytes from patients with myasthenia gravis: possible role in autoimmune pathogenesis. J. Neuroimmunol 1989; 24: 75–85
   PubMedGoogle Scholar
• Lisak R. P., Zweiman B., Phillips S. M. Thymic and peripheral blood T- and B-cell levels in myasthenia gravis. Neurology 1978; 28: 1298–1301
   PubMedGoogle Scholar
• Aisen P. Transferrin, the transferrin receptor, and the uptake of iron by cells. Mel. Ions Biol. Sv.st. 1998; 35: 585–631
   PubMedGoogle Scholar
• Burns G. F., Triglia T., Werkmeister J. A., Begley C. G., Boyd A. W. TLiSAl, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors. J. Exp. Med 1985; 161: 1063–1078
   PubMed Web of Science ®Google Scholar
• Fujii N., Itoyama Y., Tabira T., Kuroiwa Y. Subsets of lymphoid cells in blood and thymus in myasthenia gravis. Monoclonal antibody analysis. J. Neuroimmunol 1983; 4: 151–159
   PubMedGoogle Scholar
• Berrih S., Gaud C., Bach M., Le Brigand H., Binet J., Bach J. Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies. Clin. Exp. Immunol 1981; 45: 1–8
   PubMed Web of Science ®Google Scholar
• Skolnik P. R., Lisak R. P., Zweiman B. Monoclonal antibody analysis of blood T cell subsets in myasthenia gravis. Aim. Neurol 1982; 11: 170–176
   PubMedGoogle Scholar
• Emery P., Gentry K. C., Mackay R. l., Muirden K. D., Rowley M. Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arthrilis Rheum 1987; 30: 849–856
   PubMed Web of Science ®Google Scholar
• Shimizu H., Ichikawa Y., Yoshida M., Tukahashi K., Arimori S. Lymphocyte subsets of the peripheral blood in myasthenia gravis determined by two-color flow cytometry. Autoimmunity 1990; 6: 173–182
   PubMed Web of Science ®Google Scholar
• Neckers L. M. Regulation of transferrin receptor expression and control of cell growth. Pathohiology 1991; 59: 11–18
   Google Scholar
• Seligman P. A., Kovar J., Gelfand E. W. Lymphocyte proliferation is controlled by both iron availability and regulation of iron uptake pathways. Pathobiologv 1992; 60: 19–26
   PubMed Web of Science ®Google Scholar
• Levinson A. I., Dziarski A., Lisak R. P., Zweiman B., Brenner T., Abramsky O. Polyclonal B-cell activity in myasthenia gravis. Neurology 1981; 31: 1198–1201
   PubMedGoogle Scholar
• Lisak R. P., Laramore C., Zweiman B., Moskovitz A. In vitro synthesis of antibodies to acetylcholine receptor by peripheral blood mononuclear cells of patients with myasthenia gravis. Neurology 1983; 33: 604–608
   PubMedGoogle Scholar
• Ragheb S., Lisak R. P. Phenotypic and functional abnormalities of B-cells in myasthenia gravis. Ann. N. Y. Acad. Sci 1993; 681: 256–263
   PubMedGoogle Scholar
• von Bonin A., Hühn I., Fleischer B. Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway. Immunological Rev 1998; 161: 43–53
   PubMed Web of Science ®Google Scholar
• Morimoto C., Schlossman S. F. The structure and function of CD26 in the T-cell immune response. Immunological Rev 1998; 161: 55–70
   PubMed Web of Science ®Google Scholar
• Street N. E., Mosmann T. R. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEBJ 1991; 5: 171–177
   PubMed Web of Science ®Google Scholar
• Chien Y. H., Jores R., Crowley M. P. Recognition by gamma/delta T cells. Ann. Rev. Immunol 1996; 14: 511–532
   PubMed Web of Science ®Google Scholar
• Kaufmann S. H.E. γ/δ and other unconventional T lymphocytes: what do they see, and what do they do?. Proe. Natl. Acad. Sci. USA 1996; 93: 2272–2279
   PubMedGoogle Scholar
• Hayday A., Geng L. -γ/δ cells regulate autoimmunity. Curr. Opinion in Immunol 1997; 9: 884–889
   PubMedGoogle Scholar
• Troncone R., Greco L., Mayer M., Paparo F., Caputo N., Micillo M., et al. Latent and potential coeliac disease. Acta Paediat 1996; 412: 10–14
   Google Scholar
• Sclmaj K., Brosnan C. F., Raine C. S. Colocalization of lymphocytes bearing gamma/delta T cell receptor and hsp 65+ oligodendrocytes in multiple sclerosis. Proe. Natl. Acad. Sci. USA 1991; 88: 6452–6456
   PubMedGoogle Scholar
• Hvas J., Oksenberg J. R., Fernando R., Steinman L., Bernard A. CC. γ/δ T cell receptor repertoire in brain lesions of patients with multiple sclerosis. J. Neuroimmu-nol 1993; 46: 225–234
   PubMedGoogle Scholar
• Shimonkevitz R., Colburn C., Burham J. A., Murray R. S., Kotzin B. L. Clonal expansions of activated γ/δ T cells in recent-onset multiple sclerosis. Proc. Nail. Acad. Sci. USA 1993; 90: 923–927
   PubMedGoogle Scholar
• Stinissen P., Vandevyver C., Medaer R., Vandegaer L., Nies J., Tuyls L., et al. Increased frequency of γ/δ T-ceils in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity. and T cell receptor V gene rearrangements. J. Immunol 1995; 154: 4883–4894
   PubMedGoogle Scholar
• Olive C. γ/δ T-cell receptor variable region usage during the development of experimental allergic encephalomyelitis. J. Neuroimmunol 1995; 62: 1–7
   PubMedGoogle Scholar
• Rajan A. J., Gao Y. L., Raine C. S., Brosnan C. F. A pathogenic role of γ/δ T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse. J. Immunol 1996; 157: 941–949
   PubMedGoogle Scholar
• Harrison L. C, Dempsey-Collier M., Kramer D. R., Takahashi K. Aerosol insulin induces regulatory CDS gamma delta T cells that prevent murine insulin-dependent diabetes. J. Exp. Med 1996; 184: 2167–2174
   PubMedGoogle Scholar
• Widner G., Hunig T., Thurau S. R. Orally-induced peptide-specific γ/δ TCR+ cells suppress experimental autoimmune uveitis. Eur. J. Immunol 1996; 26: 2140–2148
   PubMedGoogle Scholar
• Kobayashi Y., Kawai K., Ito K., Honda H., Soube G., Yoshikai Y. Aggravation of murine experimental allergic encephalomyelitis by administration of T-cell receptor γ/δ specific antibody. J. Neuroimmunol 1997; 73: 169–174
   PubMed Web of Science ®Google Scholar